ZHYPER PRIME

Serial Number 88745015
606

Registration Progress

Application Filed
Jan 2, 2020
Under Examination
Jun 23, 2020
Approved for Publication
Apr 28, 2020
Published for Opposition
Apr 28, 2020
Registered

Basic Information

Serial Number
88745015
Filing Date
January 2, 2020
Published for Opposition
April 28, 2020
Abandonment Date
January 25, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 25, 2021
Classes
005

Rights Holder

ZTI KOREA CO., LTD.

99
Address
#1109
6, Teheran-ro 52-gil, Gangnam-gu
Seoul 06211
KR

Ownership History

ZTI KOREA CO., LTD.

Original Applicant
99
Seoul KR

ZTI KOREA CO., LTD.

Owner at Publication
99
Seoul KR

Legal Representation

Attorney
George A. Pelletier, Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

11 events
Date Code Type Description
Jan 25, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jan 25, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 23, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 28, 2020 PUBO A PUBLISHED FOR OPPOSITION
Apr 28, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 8, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2020 DOCK D ASSIGNED TO EXAMINER
Jan 9, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; compounds for treating cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005